{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:44:15Z","timestamp":1790171055286,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2011,12,22]],"date-time":"2011-12-22T00:00:00Z","timestamp":1324512000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"DOI":"10.1038\/cddis.2011.131","type":"journal-article","created":{"date-parts":[[2011,12,22]],"date-time":"2011-12-22T12:05:52Z","timestamp":1324555552000},"page":"e245-e245","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The role of c-FLIP splice variants in urothelial tumours"],"prefix":"10.1038","volume":"2","author":[{"given":"F","family":"Ewald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Ueffing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Brockmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Hader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Telieps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W A","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,22]]},"reference":[{"key":"BFcddis2011131_CR1","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrc776","volume":"2","author":"FH Igney","year":"2002","unstructured":"Igney FH, Krammer PH . Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer 2002; 2: 277\u2013288.","journal-title":"Nat Rev Cancer"},{"key":"BFcddis2011131_CR2","doi-asserted-by":"crossref","unstructured":"Shirley S, Micheau O . Targeting c-FLIP in cancer. Cancer Lett 2010; e-pub ahead of print 9 November 2010; doi:10.1016\/j.canlet.2010.10.009.","DOI":"10.1016\/j.canlet.2010.10.009"},{"key":"BFcddis2011131_CR3","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1074\/jbc.274.3.1541","volume":"274","author":"C Scaffidi","year":"1999","unstructured":"Scaffidi C, Schmitz I, Krammer PH, Peter ME . The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem 1999; 274: 1541\u20131548.","journal-title":"J Biol Chem"},{"key":"BFcddis2011131_CR4","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/40657","volume":"388","author":"M Irmler","year":"1997","unstructured":"Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V et al. Inhibition of death receptor signals by cellular FLIP. Nature 1997; 388: 190\u2013195.","journal-title":"Nature"},{"key":"BFcddis2011131_CR5","doi-asserted-by":"publisher","first-page":"14507","DOI":"10.1074\/jbc.M414425200","volume":"280","author":"A Golks","year":"2005","unstructured":"Golks A, Brenner D, Fritsch C, Krammer PH, Lavrik IN . c-FLIPR, a new regulator of death receptor-induced apoptosis. J Biol Chem 2005; 280: 14507\u201314513.","journal-title":"J Biol Chem"},{"key":"BFcddis2011131_CR6","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1182\/blood-2009-02-204230","volume":"114","author":"N Ueffing","year":"2009","unstructured":"Ueffing N, Singh KK, Christians A, Thorns C, Feller AC, Nagl F et al. A single nucleotide polymorphism determines protein isoform production of the human c-FLIP protein. Blood 2009; 114: 572\u2013579.","journal-title":"Blood"},{"key":"BFcddis2011131_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/sj.cdd.4401186","volume":"10","author":"ME Peter","year":"2003","unstructured":"Peter ME, Krammer PH . The CD95(APO-1\/Fas) DISC and beyond. Cell Death Differ 2003; 10: 26\u201335.","journal-title":"Cell Death Differ"},{"key":"BFcddis2011131_CR8","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S1097-2765(03)00051-0","volume":"11","author":"KM Boatright","year":"2003","unstructured":"Boatright KM, Renatus M, Scott FL, Sperandio S, Shin H, Pedersen IM et al. A unified model for apical caspase activation. Mol Cell 2003; 11: 529\u2013541.","journal-title":"Mol Cell"},{"key":"BFcddis2011131_CR9","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.1093\/emboj\/cdg414","volume":"22","author":"DW Chang","year":"2003","unstructured":"Chang DW, Xing Z, Capacio VL, Peter ME, Yang X . Interdimer processing mechanism of procaspase-8 activation. EMBO J 2003; 22: 4132\u20134142.","journal-title":"EMBO J"},{"key":"BFcddis2011131_CR10","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S1097-2765(03)00059-5","volume":"11","author":"M Donepudi","year":"2003","unstructured":"Donepudi M, Mac Sweeney A, Briand C, Grutter MG . Insights into the regulatory mechanism for caspase-8 activation. Mol Cell 2003; 11: 543\u2013549.","journal-title":"Mol Cell"},{"key":"BFcddis2011131_CR11","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/sj.cdd.4402314","volume":"15","author":"N Ueffing","year":"2008","unstructured":"Ueffing N, Keil E, Freund C, Kuhne R, Schulze-Osthoff K, Schmitz I . Mutational analyses of c-FLIPR, the only murine short FLIP isoform, reveal requirements for DISC recruitment. Cell Death Differ 2008; 15: 773\u2013782.","journal-title":"Cell Death Differ"},{"key":"BFcddis2011131_CR12","doi-asserted-by":"publisher","first-page":"20633","DOI":"10.1074\/jbc.M101780200","volume":"276","author":"A Krueger","year":"2001","unstructured":"Krueger A, Schmitz I, Baumann S, Krammer PH, Kirchhoff S . Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signalling complex. J Biol Chem 2001; 276: 20633\u201320640.","journal-title":"J Biol Chem"},{"key":"BFcddis2011131_CR13","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/nri1787","volume":"6","author":"RC Budd","year":"2006","unstructured":"Budd RC, Yeh WC, Tschopp J . cFLIP regulation of lymphocyte activation and development. Nat Rev Immunol 2006; 6: 196\u2013204.","journal-title":"Nat Rev Immunol"},{"key":"BFcddis2011131_CR14","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1093\/emboj\/cdf356","volume":"21","author":"DW Chang","year":"2002","unstructured":"Chang DW, Xing Z, Pan Y, Algeciras-Schimnich A, Barnhart BC, Yaish-Ohad S et al. c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. EMBO J 2002; 21: 3704\u20133714.","journal-title":"EMBO J"},{"key":"BFcddis2011131_CR15","doi-asserted-by":"publisher","first-page":"45162","DOI":"10.1074\/jbc.M206882200","volume":"277","author":"O Micheau","year":"2002","unstructured":"Micheau O, Thome M, Schneider P, Holler N, Tschopp J, Nicholson DW et al. The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. J Biol Chem 2002; 277: 45162\u201345171.","journal-title":"J Biol Chem"},{"key":"BFcddis2011131_CR16","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1083\/jcb.201002060","volume":"190","author":"N Fricker","year":"2010","unstructured":"Fricker N, Beaudouin J, Richter P, Eils R, Krammer PH, Lavrik IN . Model-based dissection of CD95 signaling dynamics reveals both a pro- and antiapoptotic role of c-FLIPL. J Cell Biol 2010; 190: 377\u2013389.","journal-title":"J Cell Biol"},{"key":"BFcddis2011131_CR17","doi-asserted-by":"publisher","first-page":"6611","DOI":"10.1073\/pnas.0400765101","volume":"101","author":"A Dutton","year":"2004","unstructured":"Dutton A, O'Neil JD, Milner AE, Reynolds GM, Starczynski J, Crocker J et al. Expression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's lymphoma cells from autonomous Fas-mediated death. Proc Natl Acad Sci USA 2004; 101: 6611\u20136616.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2011131_CR18","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1084\/jem.20031080","volume":"199","author":"S Mathas","year":"2004","unstructured":"Mathas S, Lietz A, Anagnostopoulos I, Hummel F, Wiesner B, Janz M et al. c-FLIP mediates resistance of Hodgkin\/Reed-Sternberg cells to death receptor-induced apoptosis. J Exp Med 2004; 199: 1041\u20131052.","journal-title":"J Exp Med"},{"key":"BFcddis2011131_CR19","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.4049\/jimmunol.161.6.2833","volume":"161","author":"TS Griffith","year":"1998","unstructured":"Griffith TS, Chin WA, Jackson GC, Lynch DH, Kubin MZ . Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. J Immunol 1998; 161: 2833\u20132840.","journal-title":"J Immunol"},{"key":"BFcddis2011131_CR20","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1084\/jem.190.7.1033","volume":"190","author":"JP Medema","year":"1999","unstructured":"Medema JP, de Jong J, van Hall T, Melief CJ, Offringa R . Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein. J Exp Med 1999; 190: 1033\u20131038.","journal-title":"J Exp Med"},{"key":"BFcddis2011131_CR21","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1084\/jem.190.7.1025","volume":"190","author":"M Djerbi","year":"1999","unstructured":"Djerbi M, Screpanti V, Catrina AI, Bogen B, Biberfeld P, Grandien A . The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors. J Exp Med 1999; 190: 1025\u20131032.","journal-title":"J Exp Med"},{"key":"BFcddis2011131_CR22","doi-asserted-by":"crossref","unstructured":"Wajant H, Gerspach J, Pfizenmaier K . Engineering death receptor ligands for cancer therapy. Cancer Lett 2011; e-pub ahead of print 13 January 2011; doi:10.1016\/j.canlet.2010.12.019.","DOI":"10.1016\/j.canlet.2010.12.019"},{"key":"BFcddis2011131_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/5517","volume":"5","author":"H Walczak","year":"1999","unstructured":"Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 1999; 5: 157\u2013163.","journal-title":"Nat Med"},{"key":"BFcddis2011131_CR24","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","volume":"3","author":"SR Wiley","year":"1995","unstructured":"Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995; 3: 673\u2013682.","journal-title":"Immunity"},{"key":"BFcddis2011131_CR25","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nrurol.2011.81","volume":"8","author":"C Voelkel-Johnson","year":"2011","unstructured":"Voelkel-Johnson C . TRAIL-mediated signaling in prostate, bladder and renal cancer. Nat Rev Urol 2011; 8: 417\u2013427.","journal-title":"Nat Rev Urol"},{"key":"BFcddis2011131_CR26","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0022-5347(05)00160-6","volume":"175","author":"HF O'Kane","year":"2006","unstructured":"O'Kane HF, Watson CJ, Johnston SR, Petak I, Watson RW, Williamson KE . Targeting death receptors in bladder, prostate and renal cancer. J Urol 2006; 175: 432\u2013438.","journal-title":"J Urol"},{"key":"BFcddis2011131_CR27","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s10555-009-9195-6","volume":"28","author":"HM Rosevear","year":"2009","unstructured":"Rosevear HM, Lightfoot AJ, O'Donnell MA, Griffith TS . The role of neutrophils and TNF-related apoptosis-inducing ligand (TRAIL) in bacillus Calmette-Guerin (BCG) immunotherapy for urothelial carcinoma of the bladder. Cancer Metastasis Rev 2009; 28: 345\u2013353.","journal-title":"Cancer Metastasis Rev"},{"key":"BFcddis2011131_CR28","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.urology.2004.01.007","volume":"63","author":"P Korkolopoulou","year":"2004","unstructured":"Korkolopoulou P, Goudopoulou A, Voutsinas G, Thomas-Tsagli E, Kapralos P, Patsouris E et al. c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations. Urology 2004; 63: 1198\u20131204.","journal-title":"Urology"},{"key":"BFcddis2011131_CR29","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/sj.cdd.4401846","volume":"13","author":"LP Steele","year":"2006","unstructured":"Steele LP, Georgopoulos NT, Southgate J, Selby PJ, Trejdosiewicz LK . Differential susceptibility to TRAIL of normal versus malignant human urothelial cells. Cell Death Differ 2006; 13: 1564\u20131576.","journal-title":"Cell Death Differ"},{"key":"BFcddis2011131_CR30","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.4049\/jimmunol.172.4.2194","volume":"172","author":"I Schmitz","year":"2004","unstructured":"Schmitz I, Weyd H, Krueger A, Baumann S, Fas SC, Krammer PH et al. Resistance of short term activated T cells to CD95-mediated apoptosis correlates with de novo protein synthesis of c-FLIPshort. J Immunol 2004; 172: 2194\u20132200.","journal-title":"J Immunol"},{"key":"BFcddis2011131_CR31","first-page":"3947","volume":"60","author":"S Fulda","year":"2000","unstructured":"Fulda S, Meyer E, Debatin KM . Metabolic inhibitors sensitise for CD95 (APO-1\/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression. Cancer Res 2000; 60: 3947\u20133956.","journal-title":"Cancer Res"},{"key":"BFcddis2011131_CR32","doi-asserted-by":"publisher","first-page":"8247","DOI":"10.1128\/MCB.21.24.8247-8254.2001","volume":"21","author":"A Krueger","year":"2001","unstructured":"Krueger A, Baumann S, Krammer PH, Kirchhoff S . FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis. Mol Cell Biol 2001; 21: 8247\u20138254.","journal-title":"Mol Cell Biol"},{"key":"BFcddis2011131_CR33","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1182\/blood-2008-02-141382","volume":"112","author":"N Ueffing","year":"2008","unstructured":"Ueffing N, Schuster M, Keil E, Schulze-Osthoff K, Schmitz I . Up-regulation of c-FLIP short by NFAT contributes to apoptosis resistance of short-term activated T cells. Blood 2008; 112: 690\u2013698.","journal-title":"Blood"},{"key":"BFcddis2011131_CR34","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1038\/sj.emboj.7600325","volume":"23","author":"BC Barnhart","year":"2004","unstructured":"Barnhart BC, Legembre P, Pietras E, Bubici C, Franzoso G, Peter ME . CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells. EMBO J 2004; 23: 3175\u20133185.","journal-title":"EMBO J"},{"key":"BFcddis2011131_CR35","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nature09075","volume":"465","author":"L Chen","year":"2010","unstructured":"Chen L, Park SM, Tumanov AV, Hau A, Sawada K, Feig C et al. CD95 promotes tumour growth. Nature 2010; 465: 492\u2013496.","journal-title":"Nature"},{"key":"BFcddis2011131_CR36","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.4161\/cc.3.10.1194","volume":"3","author":"P Legembre","year":"2004","unstructured":"Legembre P, Barnhart BC, Peter ME . The relevance of NF-kappaB for CD95 signaling in tumor cells. Cell Cycle 2004; 3: 1235\u20131239.","journal-title":"Cell Cycle"},{"key":"BFcddis2011131_CR37","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1083\/jcb.200401036","volume":"166","author":"S Kreuz","year":"2004","unstructured":"Kreuz S, Siegmund D, Rumpf JJ, Samel D, Leverkus M, Janssen O et al. NFkappaB activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP. J Cell Biol 2004; 166: 369\u2013380.","journal-title":"J Cell Biol"},{"key":"BFcddis2011131_CR38","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.molcel.2011.06.011","volume":"43","author":"M Feoktistova","year":"2011","unstructured":"Feoktistova M, Geserick P, Kellert B, Dimitrova DP, Langlais C, Hupe M et al. cIAPs block Ripoptosome formation, a RIP1\/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol Cell 2011; 43: 449\u2013463.","journal-title":"Mol Cell"},{"key":"BFcddis2011131_CR39","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.molcel.2011.06.006","volume":"43","author":"T Tenev","year":"2011","unstructured":"Tenev T, Bianchi K, Darding M, Broemer M, Langlais C, Wallberg F et al. The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol Cell 2011; 43: 432\u2013448.","journal-title":"Mol Cell"},{"key":"BFcddis2011131_CR40","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1006\/excr.2002.5647","volume":"282","author":"S Swiatkowski","year":"2003","unstructured":"Swiatkowski S, Seifert HH, Steinhoff C, Prior A, Thievessen I, Schliess F et al. Activities of MAP-kinase pathways in normal uroepithelial cells and urothelial carcinoma cell lines. Exp Cell Res 2003; 282: 48\u201357.","journal-title":"Exp Cell Res"}],"container-title":["Cell Death & Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cddis2011131.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cddis2011131","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2011131.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T23:44:36Z","timestamp":1672962276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis2011131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,22]]},"references-count":40,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2011,12]]}},"alternative-id":["BFcddis2011131"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2011.131","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,22]]},"assertion":[{"value":"24 October 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}